miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α
- PMID: 25891797
- PMCID: PMC4622471
- DOI: VSports app下载 - 10.1080/15384047.2015.1030545
miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α
Abstract
Background: Our previous findings showed that miR-33 expressed abnormally in clinical specimens of melanoma, but the exact molecular mechanism has not been elucidated. VSports手机版.
Object: To determine miR-33's roles in melanoma and confirm whether HIF-1α is a direct target gene of miR-33a V体育安卓版. .
Methods: First miR-33a/b expression levels were detected in HM, WM35, WM451, A375 and SK-MEL-1. Then lentiviral vectors were constructed to intervene miR-33a expression in melanoma cells V体育ios版. Cell proliferation, invasion and metastasis were detected. A375 cells mice model was performed to test the tumorigenesis of melanoma in vivo. Finally the dual reporter gene assay was carried out to confirm whether HIF-1α is a direct target gene of miR-33a. .
Results: MiR-33a/b exhibited a lower expression in WM35, WM451, A375 and SK-MEL-1 of the metastatic skin melanoma cell lines than that in HM. Then inhibition of miR-33a expression in WM35 and WM451 cell lines could promote cell proliferation, invasion and metastasis VSports最新版本. Conversely, increased expression of miR-33a in A375 cells could inhibit cellproliferation, invasion and metastasis. In vivo tests also confirmed that overexpression of miR-33a in A375 cells significantly inhibited melanoma tumorigenesis. Finally, we confirmed that HIF-1α is a direct target gene of miR-33a. .
Conclusion: The newly identified miR-33a/HIF-1α axis might provide a new strategy for the treatment of melanoma V体育平台登录. .
Keywords: HIF-1α; HIF-1α, hypoxia inducible factor 1, α subunit; cell proliferation; invasion; melanoma; metastasis; miR-33a; miR-33a/b, microRNA 33a/b; microRNAs VSports注册入口. .
Figures
References
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013 - DOI - PubMed
-
- Segura MF, Greenwald HS, Hanniford D, Osman I, Hernando E. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis 2012; 33:1823-32; PMID:22693259; http://dx.doi.org/10.1093/carcin/bgs205 - DOI - PMC - PubMed
-
- Dong F, Lou D. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Mol Vis 2012; 18:537-46; PMID:22419847 - "V体育官网入口" PMC - PubMed
-
- Luo C, Tetteh PW, Merz PR, Dickes E, Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek B, Schadendorf D, et al.. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J Invest Dermatol 2013; 133:768-75; PMID:23151846; http://dx.doi.org/10.1038/jid.2012.357 - DOI - PubMed
-
- Dar AA, Majid S, Rittsteuer C, de Semir D, Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR 3rd, Kashani-Sabet M. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst 2013; 105:433-42; PMID:23365201; "V体育2025版" http://dx.doi.org/10.1093/jnci/djt003 - DOI - PMC - PubMed
Publication types
- "V体育ios版" Actions
MeSH terms
- "V体育官网入口" Actions
- "V体育安卓版" Actions
- "VSports在线直播" Actions
- V体育官网 - Actions
- VSports注册入口 - Actions
- "VSports最新版本" Actions
- Actions (V体育官网入口)
- "VSports在线直播" Actions
- Actions (V体育ios版)
Substances
- "V体育官网" Actions
- V体育平台登录 - Actions
- Actions (V体育官网入口)
LinkOut - more resources
V体育平台登录 - Full Text Sources
Other Literature Sources
Medical